Vascular Dementia (VaD) Drugs Market by Drug Class (Cholinesterase Inhibitors, NMDA Receptor Modulators, and Others), by Formulation (Capsule, Patch, Liquid, and Injectable), by Route of Administration (Oral, Transdermal, Parenteral, Subcutaneous, and Sublingual), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online), and by Application (Post-Stroke Cognitive Impairment, Mild Vascular Dementia, and Others) – Global Opportunity Analysis and Industry Forecast, 2025–2030
